<?xml version="1.0" encoding="UTF-8"?>
<ref id="B16">
 <label>16</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Kemeny</surname>
    <given-names>N</given-names>
   </name>
   <name>
    <surname>Jarnagin</surname>
    <given-names>W</given-names>
   </name>
   <name>
    <surname>Paty</surname>
    <given-names>P</given-names>
   </name>
   <name>
    <surname>Gonen</surname>
    <given-names>M</given-names>
   </name>
   <name>
    <surname>Schwartz</surname>
    <given-names>L</given-names>
   </name>
   <name>
    <surname>Morse</surname>
    <given-names>M</given-names>
   </name>
   <etal/>
  </person-group>. 
  <article-title>Phase I Trial of Systemic Oxaliplatin Combination Chemotherapy With Hepatic Arterial Infusion in Patients With Unresectable Liver Metastases From Colorectal Cancer</article-title>. 
  <source>J Clin Oncol</source> (
  <year>2005</year>) 
  <volume>23</volume>:
  <page-range>4888–96</page-range>.  
  <pub-id pub-id-type="doi">10.1200/JCO.2005.07.100</pub-id>
 </mixed-citation>
</ref>
